quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:53:21·43d
SECFiling
Vivid Seats Inc. logo

SEC Form 10-K filed by Vivid Seats Inc.

SEAT· Vivid Seats Inc.
Consumer Discretionary
Full content unavailable. See the original source below.
Original source

Companies

  • SEAT
    Vivid Seats Inc.
    Consumer Discretionary

Recent analyst ratings

  • Mar 13UpdateCraig Hallum$15.00
  • Oct 23UpdateCitigroup$13.00
  • Aug 6UpdateCanaccord Genuity$23.00
  • Aug 5UpdateCraig Hallum$2.00
  • May 6UpdateWilliam Blair-
  • Mar 13UpdateBofA Securities$2.60

Related

  • PR1d
    Vivid Seats to Report First Quarter 2026 Financial Results
  • INSIDER37d
    Chief Financial Officer Thomas Joseph D. Jr. converted options into 19,113 shares and covered exercise/tax liability with 7,960 shares (SEC Form 4)
  • INSIDER41d
    Chief Executive Officer Fey Lawrence converted options into 111,337 shares, increasing direct ownership by 150% to 185,428 units (SEC Form 4)
  • INSIDER41d
    Chief Accounting Officer Pickus Edward converted options into 15,543 shares and covered exercise/tax liability with 6,417 shares, increasing direct ownership by 143% to 15,506 units (SEC Form 4)
  • INSIDER41d
    General Counsel Arnett Austin converted options into 3,930 shares, covered exercise/tax liability with 1,491 shares and sold $1,255 worth of shares (247 units at $5.08), increasing direct ownership by 450% to 2,679 units (SEC Form 4)
  • INSIDER41d
    Chief Technology Officer Langenbacher Stefano covered exercise/tax liability with 25,620 shares and converted options into 57,836 shares, increasing direct ownership by 356% to 41,266 units (SEC Form 4)
  • ANALYST41d
    Vivid Seats upgraded by Craig Hallum with a new price target
  • SEC43d
    Vivid Seats Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022